- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Lineage Grow Company Ltd. (CSE:BUDD) announced last March 2, 2018 that it received final approval from the Canadian Securities Exchange. The company began trading today, Monday, March 5th, on the CSE under the symbol “BUDD”.
Lineage Grow Company Ltd. (CSE:BUDD) announced last March 2, 2018 that it received final approval from the Canadian Securities Exchange. The company began trading today, Monday, March 5th, on the CSE under the symbol “BUDD”.
The CSE would like to welcome Lineage Grow Company Ltd. (CSE:BUDD) to the exchange! View listing: https://t.co/2HEDVWOqSh pic.twitter.com/ChXwTSTAYB
— CSE (@CSE_News) March 5, 2018
Click here to connect with Lineage Grow Company Ltd. (CSE:BUDD) for an Investor Presentation
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.